PedAM
Pediatric Disease Annotations & Medicines
| Disease | antiphospholipid syndrome |
| Symptom | C0040038|thromboembolism |
| Sentences | 5 |
| PubMedID- 22635217 | Secondary prevention of venous thromboembolism in antiphospholipid syndrome (aps) is usually made using vitamin k antagonists (vkas) to maintain an international normalized ratio (inr) between 2.0 and 3.0. |
| PubMedID- 25118790 | Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. |
| PubMedID- 20353992 | Anticoagulation with oral vitamin k antagonists (vka) is the mainstay of the treatment of venous and/or arterial thromboembolism in patients with antiphospholipid syndrome (aps), although the optimal intensity of anticoagulation remains controversial. |
| PubMedID- 25043836 | New oral anticoagulants may not be effective to prevent venous thromboembolism in patients with antiphospholipid syndrome. |
| PubMedID- 22425342 | She developed recurrent pulmonary thromboembolism and was diagnosed with antiphospholipid syndrome. |
Page: 1